Cigna Group stock underperforms rivals despite rising

8 articles · Updated · MarketWatch · May 8

Shares climbed 1.42% to $288.06 on Friday, marking a third straight gain as the S&P 500 rose 0.84% and the Dow added 0.02%.
Cigna still lagged major health-insurance peers, with UnitedHealth up 2.77%, CVS Health gaining 3.65%, and Elevance Health edging 1.38% higher.
The stock finished 15% below its 52-week high of $338.89, reached on 1 July, despite the broader market's strong session.

Cigna's profits are soaring, so why is its stock falling behind key industry rivals?

With rivals betting big on AI, is Cigna falling behind in the healthcare tech race?

As new laws dismantle PBM secrecy, can Cigna's top-ranked pharmacy business maintain its dominance?